A mitophagy inhibitor targeting p62 attenuates the leukemia-initiation potential of acute myeloid leukemia cells.

[1]  Mark R. Marten,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 , 2021, Autophagy.

[2]  J. Cheong,et al.  PERK/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells , 2020, Journal of experimental & clinical cancer research : CR.

[3]  J. Bourhis,et al.  Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long‐term follow up of a phase III study , 2020, American journal of hematology.

[4]  L. Rassenti,et al.  NF-κB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia , 2020, Cell Death & Differentiation.

[5]  D. Vetrie,et al.  The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML , 2020, Nature Reviews Cancer.

[6]  S. Mousa,et al.  Current and Future Molecular Targets for Acute Myeloid Leukemia Therapy , 2020, Current Treatment Options in Oncology.

[7]  E. Vellenga,et al.  Differential redox-regulation and mitochondrial dynamics in normal and leukemic hematopoietic stem cells: A potential window for leukemia therapy. , 2019, Critical reviews in oncology/hematology.

[8]  G. Sethi,et al.  Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements , 2019, Biomolecules.

[9]  S. Bohlander,et al.  The cell of origin and the leukemia stem cell in acute myeloid leukemia , 2019, Genes, chromosomes & cancer.

[10]  M. Nykter,et al.  Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma , 2019, Oncogene.

[11]  J. Debnath,et al.  Targeting Autophagy in Cancer: Recent Advances and Future Directions. , 2019, Cancer discovery.

[12]  Ling Wang,et al.  The Multifunctional Protein p62 and Its Mechanistic Roles in Cancers. , 2019, Current cancer drug targets.

[13]  J. Quadrilatero,et al.  Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation , 2019, Autophagy.

[14]  L. Bullinger,et al.  New Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise , 2019, International journal of molecular sciences.

[15]  L. Papa,et al.  Mitochondrial Role in Stemness and Differentiation of Hematopoietic Stem Cells , 2019, Stem cells international.

[16]  The Duy Nguyen,et al.  Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy. , 2019, Blood.

[17]  J. Blay,et al.  Knockdown of BNIP3L or SQSTM1 alters cellular response to mitochondria target drugs , 2019, Autophagy.

[18]  M. Voso,et al.  The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells , 2018, Haematologica.

[19]  A. Thorburn,et al.  ZZ-dependent regulation of p62/SQSTM1 in autophagy , 2018, Nature Communications.

[20]  G. Helgason,et al.  Targeting quiescent leukemic stem cells using second generation autophagy inhibitors , 2018, Leukemia.

[21]  John M. Ashton,et al.  AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells. , 2018, Cell stem cell.

[22]  X. Xie,et al.  XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome Differentiation Suppression , 2018, Front. Endocrinol..

[23]  T. Lamark,et al.  Regulation of selective autophagy: the p62/SQSTM1 paradigm. , 2017, Essays in biochemistry.

[24]  Lorenzo Galluzzi,et al.  Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles , 2017, Nature Reviews Drug Discovery.

[25]  J. Guan,et al.  Autophagy is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and anti-leukemic effect of chloroquine , 2017, Autophagy.

[26]  H. Hackl,et al.  Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia , 2017, Journal of Hematology & Oncology.

[27]  Bob Löwenberg,et al.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. , 2017, Blood.

[28]  J. Cheong,et al.  Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells , 2017, Autophagy.

[29]  J. D'haese,et al.  Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy , 2016, Journal of cellular physiology.

[30]  Morgan Sheng,et al.  Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond. , 2016, Free radical biology & medicine.

[31]  Ying-dai Gao,et al.  Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells , 2016, Journal of Hematology & Oncology.

[32]  I. de Kouchkovsky,et al.  ‘Acute myeloid leukemia: a comprehensive review and 2016 update' , 2016, Blood Cancer Journal.

[33]  Zhijie Kang,et al.  p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA , 2016, Oncogene.

[34]  Shujiro Okuda,et al.  p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming , 2016, Nature Communications.

[35]  Jin-Ming Yang,et al.  Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia , 2016, Oncotarget.

[36]  G. Zheng,et al.  Leukemic marrow infiltration reveals a novel role for Egr3 as a potent inhibitor of normal hematopoietic stem cell proliferation. , 2015, Blood.

[37]  D. Ferguson,et al.  Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia , 2015, Cell Death Discovery.

[38]  Wei Zhao,et al.  Blocking the ZZ Domain of Sequestosome1/p62 Suppresses Myeloma Growth and Osteoclast Formation In Vitro and Induces Dramatic Bone Formation in Myeloma-Bearing Bones In Vivo , 2015, Leukemia.

[39]  E. Sausville,et al.  Autophagy modulation: a target for cancer treatment development , 2015, Cancer Chemotherapy and Pharmacology.

[40]  M. Tschan,et al.  p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells , 2014, Cell Death and Differentiation.

[41]  José Magalhães,et al.  Mitochondria in Health and Disease , 2014, Oxidative medicine and cellular longevity.

[42]  X. Xie,et al.  Blocking the ZZ Domain of Sequestosome 1/p62 Suppress the Enhancement of Myeloma Cell Growth and Osteoclast Formation by Marrow Stromal Cells , 2011 .

[43]  E. Soilleux,et al.  The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance , 2011, The Journal of experimental medicine.

[44]  Fabienne C. Fiesel,et al.  PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.

[45]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[46]  J. Licht,et al.  New molecular concepts and targets in acute myeloid leukemia , 2008, Current opinion in hematology.

[47]  Satoshi Tanaka,et al.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region , 2007, Nature Biotechnology.

[48]  G. Bjørkøy,et al.  p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by Autophagy* , 2007, Journal of Biological Chemistry.

[49]  A. Neubauer,et al.  Characteristics and analysis of normal and leukemic stem cells: current concepts and future directions , 2000, Leukemia.

[50]  M. Cleary,et al.  Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL , 1997, The EMBO journal.

[51]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[52]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[53]  Luan Fj.  [Establishment of the multidrug-resistant cell line K562/A02 and its drug-resistant properties]. , 1993 .

[54]  F. Luan.  [Establishment of the multidrug-resistant cell line K562/A02 and its drug-resistant properties]. , 1993, Zhonghua zhong liu za zhi [Chinese journal of oncology].